Author: Cranius

Posted Date:

February 18, 2026

CraniUS Therapeutics Appoints Johnson & Johnson Senior Executive, Oray Boston Jr. to Board of Directors

Cranius

February 18, 2026
CraniUS Therapeutics Closes $20 Million Series B Round to Advance NeuroPASS™ Platform Towards Future Commercialization

Cranius

January 28, 2026